Concepedia

Samy Jambon

SJ

Statistics

Publications

6

Citations

307

H-Index

6

Active since

2017

Affiliations

Inserm(Current)

Université de Lille

Centre de Recherche Jean Pierre Aubert

Institut pour la Recherche sur le Cancer de Lille

Georgia State University

Samy Jambon is an author at Inserm specializing in medicinal chemistry, dna-binding motifs, and medicine.

ORCID

Publications per year

2017–2024

6

Publications

6

Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma

Babak Moghimi, Sakunthala Muthugounder, Samy Jambon et al. · Nature Communications · 2021 · 156 citations · Full text

, , +14

Novel amidino substituted benzimidazole and benzothiazole benzo[b]thieno-2-carboxamides exert strong antiproliferative and DNA binding properties

Maja Cindrić, Samy Jambon, Anja Harej et al. · European Journal of Medicinal Chemistry · 2017 · 53 citations

, , +8

Heterocyclic Diamidine DNA Ligands as HOXA9 Transcription Factor Inhibitors: Design, Molecular Evaluation, and Cellular Consequences in a HOXA9-Dependant Leukemia Cell Model

Sabine Depauw, Mélanie Lambert, Samy Jambon et al. · Journal of Medicinal Chemistry · 2019 · 44 citations · Full text

, , +14

Synthesis, antitumor activity and DNA binding features of benzothiazolyl and benzimidazolyl substituted isoindolines

Irena Sović, Samy Jambon, Sandra Kraljević Pavelić et al. · Bioorganic & Medicinal Chemistry · 2018 · 27 citations

, , +14

CD33–CD123 IF-THEN Gating Reduces Toxicity while Enhancing the Specificity and Memory Phenotype of AML-Targeting CAR-T Cells

Samy Jambon, Jianping Sun, Shawn Barman et al. · Blood Cancer Discovery · 2024 · 16 citations · Full text

, , +17

1–5 of 6